APP-based Multifaceted Management After PCI
- Conditions
- Percutaneous Coronary Intervention
- Interventions
- Other: APP-based multifaceted management
- Registration Number
- NCT03059784
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Brief Summary
High rates of recurrent cardiovascular events and readmission after percutaneous coronary intervention (PCI) are important issues. Guidelines emphasize rehabilitation and secondary prevention. But many patients are lack of effective management after PCI.This study is aimed to examine the effect of mobile application (APP)-based multifaceted management on the improvement of long-term care after PCI.
- Detailed Description
This is a cluster-randomized controlled trial to evaluate the effect of APP-based multifaceted management strategy on improvement of long-term care for medication adherence,risk factor control, and reduction of adverse events, readmission rate and mortality after PCI.It includes knowledge education, medication reminder,advice provision, support to change lifestyle behaviors. The program is interactive between care provider and patients. A total of 20 wards will be randomly assigned to intervention or usual care.Anticipated 1100 patients after PCI will be participated in the trial. All the participants will be followed up until 12 months.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1100
- patients who have received percutaneous coronary intervention and are discharged alive in the study centers;
- patients who are able to use APP;
- patients who provide informed consent.
- patients who are not able to use APP;
- dementia;
- mental disturbed;
- patients who are not willing to receive management and follow up.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description intervention APP-based multifaceted management APP-based multifaceted management, including sending education material, everyday medication reminder, giving risk factor control support, clinical support to patients after PCI through APP.
- Primary Outcome Measures
Name Time Method evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications) at 12 months after PCI the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications
- Secondary Outcome Measures
Name Time Method rate of systolic blood pressure achieving target at 12 months after PCI rate of systolic blood pressure achieving target based on guideline
readmission rate 12 months after PCI readmission rate after PCI
rate of LDL-C achieving target at 12 months after PCI rate of LDL-C achieving target based on guideline